ChiCTR2000033378 版本V1.0 版本创建时间2020/05/30 14:24:36 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2000033378 

最近更新日期:

Date of Last Refreshed on:

2020-05-30 14:24:01 

注册时间:

Date of Registration:

1990-01-01 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

待编辑(五) 超声引导下的椎旁神经阻滞联合腰方肌阻滞在经皮肾镜碎石术中的应用研究

Public title:

The application of ultrasound-guided paravertebral nerve block combined with quadrate lumbar block in percutaneous nephrolithotripsy

注册题目简写:

超声引导下的神经阻滞在经皮肾镜碎石术中的应用

English Acronym:

Application of ultrasound-guided nerve block in percutaneous nephrolithotripsy

研究课题的正式科学名称:

超声引导下的椎旁神经阻滞联合腰方肌阻滞在经皮肾镜碎石术中的应用研究

Scientific title:

The application of ultrasound-guided paravertebral nerve block combined with quadrate lumbar block in percutaneous nephrolithotripsy

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

吴召召 

研究负责人:

叶青山 

Applicant:

Wuzhaozhao 

Study leader:

YeQingshan 

申请注册联系人电话:

Applicant telephone:

15909675605

研究负责人电话:

Study leader's telephone:

17395055188

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

958602650@qq.com

研究负责人电子邮件:

Study leader's E-mail:

yeqingshan@hotmail.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

宁夏区银川市金凤区正源北街301号

研究负责人通讯地址:

宁夏银川市金凤区正源北街301号

Applicant address:

301 zhengyuan bei jie, jinfeng district, yinchuan city, ningxia district

Study leader's address:

301 zhengyuan bei jie, jinfeng district, yinchuan city, ningxia district

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

宁夏回族自治区人民医院麻醉科

Applicant's institution:

Ningxiahui autonomous region people's hospital. Department of anesthesiology

研究负责人所在单位:

宁夏回族自治区人民医院麻醉科

Affiliation of the Leader:

Ningxiahui autonomous region people's hospital. Department of anesthesiology

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2020-KY-GZR013

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

宁夏回族自治区人民医院伦理委员会

Name of the ethic committee:

Ningxia hui autonomous region people's hospital ethics committee

伦理委员会批准日期:

Date of approved by ethic committee:

2020-03-20 00:00:00

伦理委员会联系人:

吴钰丽

Contact Name of the ethic committee:

Wuyuli

伦理委员会联系地址:

宁夏区银川市金凤区正源北街301号

Contact Address of the ethic committee:

301 zhengyuan bei jie, jinfeng district, yinchuan city, ningxia district

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

宁夏回族自治区人民医院麻醉科

Primary sponsor:

Ningxiahui autonomous region people's hospital. Department of anesthesiology

研究实施负责(组长)单位地址:

宁夏区银川市金凤区正源北街301号

Primary sponsor's address:

301 zhengyuan bei jie, jinfeng district, yinchuan city, ningxia district

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

宁夏回族自治区

市(区县):

银川

Country:

China

Province:

Ningxia Hui Autonomous

City:

Yinchuan

单位(医院):

宁夏回族自治区人民医院麻醉科

具体地址:

金凤区正源北街301号

Institution
hospital:

Department of Anesthesiology, people's Hospital of Ningxia Hui Autonomous Region

Address:

301 Zhengyuan Street North, Jinfeng District

经费或物资来源:

科研经费

Source(s) of funding:

Scientific research funds

Target disease:

The application of ultrasound-guided paravertebral nerve block combined with quadrate lumbar block in percutaneous nephrolithotripsy

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机抽样 

Study design:

Randomly Sampling 

研究目的:

为经皮肾镜碎石术患者提供更加优化的麻醉方案  

Objectives of Study:

To provide a more optimized anesthesia program for patients undergoing percutaneous nephrolithotripsy

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

拟择期行经皮肾镜碎石术的患者
ASAII-III级,年龄>18岁,BMI<30kg/m2
无严重脑、肝、肾病史
通过伦理委员会审核且签署知情同意

Inclusion criteria

Patients who were scheduled to undergo percutaneous nephrolithotripsy
ASAII-III,Age>18,BMI<30kg/m2
No history of severe brain, liver or kidney disease
Approved by the ethics committee and signed informed consent

排除标准:

局部麻醉药过敏
穿刺部位有肿瘤或感染
有严重出血倾向者
患者及家属拒绝签署知情同意书
患者对研究中所使用的药物和器材有过敏的现象

Exclusion criteria:

Allergic to local anesthetics
There is a tumor or infection at the puncture site
Has the serious bleeding tendency
The patient and his family refused to sign the informed consent
The patients were allergic to the drugs and equipment used in the study

研究实施时间:

Study execute time:

From 2020-06-01 00:00:00 To 2021-05-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2020-06-01 00:00:00 To 2021-05-31 00:00:00  

干预措施:

Interventions:

组别:

对照组

样本量:

40

Group:

control group

Sample size:

干预措施:

胸椎旁神经阻滞

干预措施代码:

Intervention:

Thoracic paravertebral nerve block

Intervention code:

组别:

试验组

样本量:

40

Group:

experimental group

Sample size:

干预措施:

胸椎旁神经阻滞联合腰方肌阻滞

干预措施代码:

Intervention:

Thoracic paravertebral nerve block combined with quadratus lumbar block

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

宁夏回族自治区 

市(区县):

银川 

Country:

China 

Province:

NingXia Hui Autonomous 

City:

Yinchuan 

单位(医院):

宁夏回族自治区人民医院麻醉科 

单位级别:

三级甲等 

Institution
hospital:

Department of Anesthesiology, Ningxiahui Autonomous Region People's Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

患者术中血压、心率、血氧饱和度、VAS评分、术中使用阿片类药物的情况

指标类型:

主要指标

Outcome:

Intraoperative blood pressure, heart rate, blood oxygen saturation, VAS score, intraoperative opioid use

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

N/A

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 90 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

计算机随机数字表法

Randomization Procedure (please state who generates the random number sequence and by what method):

Computer random number table method

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

方式:以原始资料为准

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Method: the original data shall prevail

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

建立CRF表采集数据

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Establish CRF table to collect data

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2020-05-30 14:24:01